# A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia

> **NCT01594983** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 58 (actual)

## Conditions studied

- Non Familial Chylocmicronemia Syndrome (Non-FCS)

## Interventions

- **DRUG:** LCQ908
- **DRUG:** Fenofibrate
- **DRUG:** Fish Oil
- **DRUG:** Placebo of LCQ908
- **DRUG:** Placebo of fenofibrate
- **DRUG:** Placebo of fish oil

## Key facts

- **NCT ID:** NCT01594983
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01594983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01594983, "A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01594983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*